Skip to main content
. 2018 Dec;10(12):6624–6635. doi: 10.21037/jtd.2018.11.03

Table 2. The comparison of patients’ characteristics between training set and validation set. There was no significant difference of patients’ characteristics between training set and validation set, including gender, age, smoking history, pathological stage, EGFR status and sample type.

Characteristic Training set (n=810) Validation set (n=200) Statistical method and P value
Gender, n (%) Pearson χ2 test, P=0.813
   Male 442 (54.6) 111 (55.5)
   Female 368 (45.4) 89 (44.5)
Age (years) Independent-samples t-test, P=0.108
   Median age 61 62
   Range 25–88 39–85
Smoking history, n (%) Pearson χ2 test, P=0.954
   Smoking 209 (25.8) 53 (26.5)
   No smoking 601 (74.2) 147 (73.5)
Pathological stage, n (%) Mann-Whitney test, P=0.149
   I 253 (31.2) 54 (27.0)
   II 40 (4.9) 9 (4.5)
   III 304 (37.5) 76 (38.0)
   IV 213 (26.3) 61 (30.5)
Genetic status, n (%) Pearson χ2 test, P=0.364
   Wild type 407 (50.2) 93 (46.5)
   Exon 19 mutation 192 (23.7) 57 (28.5)
   Exon 21 mutation 211 (26.0) 50 (25.0)
Sample type, n (%) Pearson χ2 test, P=0.81
   Biopsy 308 (38.0) 78 (39.0)
   Surgery 502 (62.0) 122 (61.0)

EGFR, epithelial growth factor receptor.